INTRODUCTION |
S1 | Koh NAKATA |
ORIGINAL ARTICLES |
S2 | Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity
Hirofumi CHIBA, Surapon PIBOONPOCANUN, Hiroaki MITSUZAWA, Koji KURONUMA, Robert C MURPHY, Dennis R VOELKER |
S11 | New concepts in collectin-mediated host defense at the air-liquid interface of the lung
Francis X McCORMACK |
S7 | Genes and transcriptional programs regulating alveolar homeostasis
Jeffrey A WHITSETT |
S12 | Biology of alveolar type II cells
Robert J MASON |
S16 | Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice
John F SEYMOUR |
S23 | The role of genetics and cigarette smoking in the development of pulmonary fibrosis
Mark P STEELE, Marcy C SPEER, Jim C LOYD, Kevin K BROWN, Aretha HERRON, Susan H SLIFER, Lauranell H BURCH, Momen WAHIDI, John A PHILLIPS, Thomas A SPORN, Holman P MCADAMS, Marvin I SCHWARZ, David A SCHWARTZ |
S24 | Surfactant catabolism
Machiko IKEGAMI |
S28 | Alveolar epithelial cells: differentiation and lung injury
Kazuhiro SUGAHARA, Joho TOKUMINE, Koji TERUYA, Tatsuo OSHIRO |
S32 | Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages
Kiyoko S AKAGAWA, Iwao KOMURO, Hiroko KANAZAWA, Toshio YAMAZAKI, Keiko MOCHIDA, Fumio KISHI |
S37 | Alveolar macrophages and emphysema in surfactant protein-D-deficient mice
Mitsuhiro YOSHIDA, Jeffrey A WHITSETT |
S41 | Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia
Yasuhiro SETOGUCHI, Tomomi IKEDA, Yoshinosuke FUKUCHI |
S46 | Regulation of inflammation and bacterial clearance by lung collectins
Hitomi SANO, Koji KURONUMA, Kazumi KUDO, Hiroaki MITSUZAWA, Morihito SATO, Seiji MURAKAMI, Yoshio KUROKI |
S51 | Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D
Hiroki TAKAHASHI, Masanori SHIRATORI, Akiko KANAI, Hirofumi CHIBA, Yoshio KUROKI, Shosaku ABE |
S55 | Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan
Yoshikazu INOUE, Koh NAKATA, Toru ARAI, Ryushi TAZAWA, Emi HAMANO, Toshihiro NUKIWA, Koichiro KUDO, Naoto KEICHO, Nobuyuki HIZAWA, Etsuro YAMAGUCHI, Ryosuke EDA, Kazunori OISHI, Yuuka MAEDA, Yukiko KOREEDA, Naohiko KODO, Mitsunori SAKATANI |
S61 | Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report
Ryushi TAZAWA, Koh NAKATA, Yoshikazu INOUE, Toshihiro NUKIWA |
S65 | Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
Koh NAKATA, Hiroko KANAZAWA, Masato WATANABE |
S70 | Pulmonary surfactant transport in alveolar type II cells
Kazuhiro OSANAI, Chiharu TSUCHIHARA, Rieko HATTA, Taku OIKAWA, Katsuma TSUCHIHARA, Masaharu IGUCHI, Toshimitsu SEKI, Masakatsu TAKAHASHI, Jyongsu HUANG, Hirohisa TOGA |
S74 | Successful treatment of congenital pulmonary alveolar proteinosis with intravenous immunoglobulin G administration
Kazutoshi CHO, Koh NAKATA, Tadashi ARIGA, Satoru OKAJIMA, Tadashi MATSUDA, Keiko UEDA, Itsuko FURUTA, Kunihiko KOBAYASHI, Hisanori MINAKAMI |